Stefan Somlo

Active 1983–2024

94
Papers
20,289
Citations
83
h-index
93
i10-index

Citations

Citations per year for Stefan Somlo1985: 6 citations1986: 5 citations1987: 4 citations1988: 2 citations1989: 4 citations1990: 4 citations1991: 8 citations1992: 14 citations1993: 11 citations1994: 17 citations1995: 24 citations1996: 30 citations1997: 55 citations1998: 44 citations1999: 86 citations2000: 123 citations2001: 120 citations2002: 146 citations2003: 237 citations2004: 260 citations2005: 247 citations2006: 297 citations2007: 307 citations2008: 242 citations2009: 274 citations2010: 314 citations2011: 223 citations2012: 158 citations2013: 173 citations2014: 256 citations2015: 158 citations2016: 113 citations2017: 163 citations2018: 147 citations2019: 473 citations2020: 533 citations2021: 401 citations2022: 338 citations2023: 217 citations2024: 356 citations2025: 162 citations2026: 1 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,876 citing papers, 37.4% of this breakdownGermany: 372 citing papers, 7.4% of this breakdownUnited Kingdom: 337 citing papers, 6.7% of this breakdownChina: 289 citing papers, 5.8% of this breakdownFrance: 194 citing papers, 3.9% of this breakdownJapan: 191 citing papers, 3.8% of this breakdownNetherlands: 190 citing papers, 3.8% of this breakdownCanada: 188 citing papers, 3.7% of this breakdownItaly: 182 citing papers, 3.6% of this breakdownBelgium: 119 citing papers, 2.4% of this breakdownAustralia: 104 citing papers, 2.1% of this breakdownSpain: 98 citing papers, 1.9% of this breakdown
0%37.4%Other 17.5%

Fields

  • Biochemistry, Genetics and Molecular Biology72.5%
  • Medicine17.1%
  • Neuroscience5.7%
  • Psychology1.6%
  • Immunology and Microbiology0.9%
  • Nursing0.5%
  • Other1.7%

Topics

  • Genetic and Kidney Cyst Diseases18.3%
  • Renal and related cancers10.4%
  • Biomedical Research and Pathophysiology3.5%
  • Genetic Syndromes and Imprinting3.3%
  • Renal Diseases and Glomerulopathies3.1%
  • Hedgehog Signaling Pathway Studies2.6%
  • Other58.8%

Coauthors

All papers

Open in search
  1. Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey B. Kopp, Matthias Kretzler, Matthew B. Lanktree, Beata S. Lipska‐Ziętkiewicz, Kathy Nicholls, Kandai Nozu, Akinlolu Ojo, Afshin Parsa, Cristian Pattaro, York Pei, Martin R. Pollak, Eugene P. Rhee, Simone Sanna‐Cherchi, Judy Savige, John A. Sayer, Francesco Scolari, John R. Sedor, Xueling Sim, Stefan Somlo, Katalin Suszták, Bamidele O. Tayo, Roser Torrá, Albertien M. van Eerde, André Weinstock, Cheryl A. Winkler, Matthias Wuttke, Hong Zhang, Jennifer King, Michael Cheung, Michel Jadoul, Wolfgang C. Winkelmayer­, Ali G. Gharavi - Kidney International 2022 cited by 187

  2. Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease

    Authors: , , , , - Nature Genetics 2013 cited by 360

  3. Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The American Journal of Human Genetics 2018 cited by 313

  4. ALG9 Mutation Carriers Develop Kidney and Liver Cysts

    Authors: , , , , , , , , , , - Journal of the American Society of Nephrology 2019 cited by 158

  5. Renal plasticity revealed through reversal of polycystic kidney disease in mice

    Authors: , , , , , , - Nature Genetics 2021 cited by 122

  6. Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1

    Authors: , , , , , , , , , , , - Human Molecular Genetics 2008 cited by 287

  7. PKD2 , a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein

    Authors: , , , , , , , , , , , , , , - Science 1996 cited by 1,418

  8. Two Populations of Node Monocilia Initiate Left-Right Asymmetry in the Mouse

    Authors: , , , , - Cell 2003 cited by 807

  9. Polycystin-2 is an intracellular calcium release channel

    Authors: , , , , , , , - Nature Cell Biology 2002 cited by 714

  10. Collagen IV Gene Mutations in Adults With Bilateral Renal Cysts and CKD

    Authors: , , , , , , , , - Kidney International Reports 2019 cited by 61

  11. Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis

    Authors: , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2011 cited by 340

  12. Epithelial-Specific Cre/lox Recombination in the Developing Kidney and Genitourinary Tract

    Authors: , , - Journal of the American Society of Nephrology 2002 cited by 326

  13. Macrophages Promote Cyst Growth in Polycystic Kidney Disease

    Authors: , , , , , , , - Journal of the American Society of Nephrology 2011 cited by 234

  14. Mcp1 Promotes Macrophage-Dependent Cyst Expansion in Autosomal Dominant Polycystic Kidney Disease

    Authors: , , , , , , , - Journal of the American Society of Nephrology 2018 cited by 112

  15. PKHD1, the Polycystic Kidney and Hepatic Disease 1 Gene, Encodes a Novel Large Protein Containing Multiple Immunoglobulin-Like Plexin-Transcription–Factor Domains and Parallel Beta-Helix 1 Repeats

    Authors: , , , , , , , , , , , , , , , , , - The American Journal of Human Genetics 2002 cited by 510

  16. Small-Molecule CFTR Inhibitors Slow Cyst Growth in Polycystic Kidney Disease

    Authors: , , , , - Journal of the American Society of Nephrology 2008 cited by 218

  17. Isolated polycystic liver disease genes define effectors of polycystin-1 function

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2017 cited by 208

  18. miR-17∼92 miRNA cluster promotes kidney cyst growth in polycystic kidney disease

    Authors: , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 cited by 180

  19. Ciliary Mechanisms of Cyst Formation in Polycystic Kidney Disease

    Authors: , , - Cold Spring Harbor Perspectives in Biology 2017 cited by 135

  20. Polycystin-2 Activation by Inositol 1,4,5-Trisphosphate-induced Ca2+ Release Requires Its Direct Association with the Inositol 1,4,5-Trisphosphate Receptor in a Signaling Microdomain

    Authors: , , , , , , , , - Journal of Biological Chemistry 2010 cited by 126

  21. The C-terminal tail of polycystin-1 suppresses cystic disease in a mitochondrial enzyme-dependent fashion

    Authors: , , , , , , , , , , , , , , - Nature Communications 2023 cited by 41

  22. Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD models

    Authors: , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2009 cited by 210

  23. Polycystin-1: a master regulator of intersecting cystic pathways

    Authors: , , - Trends in Molecular Medicine 2014 cited by 129

  24. The polycystins are modulated by cellular oxygen-sensing pathways and regulate mitochondrial function

    Authors: , , , , , , , , , , , - Molecular Biology of the Cell 2016 cited by 101